Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Boston Scientific Q3
Boston Scientific Q3: Good Growth, But Not Good Enough To Justify Its P/E Ratio
Analysis of Boston Scientific Corporation's Q3 results, future growth projections, and potential impact of regulatory approvals on the stock. Click for more on BSX.
Boston Scientific Corporation (NYSE:BSX) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Call Transcript October 23, 2024 Boston Scientific Corporation beats earnings expectations. Reported EPS is $0.63, expectations were $0.588. Operator: Good morning and welcome to the Boston Scientific Third Quarter 2024 Earnings Call.
Boston Scientific Q3 Earnings Preview
In this photo illustration, a Boston Scientific Corporation logo seen ... [+] displayed on a smartphone and pc screen in the background. (Photo Illustration
1d
Boston Scientific Q3 Earnings: Revenue And EPS Beat, Lifts Annual Forecast On Strong Demand For Heart Devices
On Wednesday, Boston Scientific Corporation (NYSE:BSX) reported third-quarter revenues of $4.21 billion, beating the ...
Yahoo Finance
1d
Boston Scientific Corp (BSX) Q3 2024 Earnings Call Highlights: Robust Growth and Strategic ...
Neurology Sales Growth: 10% in
Q3
2024. Endoscopy Sales Growth: 7% organically in
Q3
2024.
Boston
Scientific
Corp ...
23h
Five things: Tax compromise, community colleges, Boston Scientific, GE Vernova and the Sacred Cod
Good morning, Boston. Here are the five things you need to know in local business news to start your busy Thursday.
1d
Boston Scientific boosts PFA expectations, citing rapid Farapulse adoption
Demand for the pulsed field ablation device drove the company’s electrophysiology sales up 177% in the third quarter compared ...
1d
Boston Scientific (BSX) Gets a Buy from Jefferies
In a report released today, Matthew Taylor from Jefferies maintained a Buy rating on Boston Scientific (BSX – Research Report), with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback